Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,075
Active & Responsive
The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
for
Hypertension
Location: Houston TX
Sponsor: Texas Southern University
Sex: All
Age: 55+
Code: NCT07413159
Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Houston TX, Pearland TX, Humble TX, Sugar Land TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase3, Recruiting
Active & Responsive
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: Houston TX, San Antonio TX, Dallas TX, McKinney TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 12+
Code: NCT06338995
Phase3, Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for
Non-small Cell Lung Cancer, NSCLC
Location: Houston TX, Little Rock AR, Albuquerque NM, Golden CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06422143
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Houston TX, Oklahoma City OK, Mobile AL, St Louis MO,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase3, Recruiting
Active & Responsive
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for
Metastatic Non-small Cell Lung Cancer
Location: Houston TX, San Antonio TX, Dallas TX, Richardson TX,
Sponsor: NovoCure GmbH
Sex: All
Age: 18+
Code: NCT06216301
Phase3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer